70 related articles for article (PubMed ID: 11188908)
1. [Naked DNA vaccines].
Spitz M
Medicina (B Aires); 2000; 60(5 Pt 1):639-44. PubMed ID: 11188908
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccination: antigen presentation and the induction of immunity.
Shedlock DJ; Weiner DB
J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
[TBL] [Abstract][Full Text] [Related]
3. Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms.
Payette PJ; Weeratna RD; McCluskie MJ; Davis HL
Gene Ther; 2001 Sep; 8(18):1395-400. PubMed ID: 11571579
[TBL] [Abstract][Full Text] [Related]
4. CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes.
Stan AC; Casares S; Brumeanu TD; Klinman DM; Bona CA
Eur J Immunol; 2001 Jan; 31(1):301-10. PubMed ID: 11265647
[TBL] [Abstract][Full Text] [Related]
5. Intradermal naked plasmid DNA immunization: mechanisms of action.
Elnekave M; Furmanov K; Hovav AH
Expert Rev Vaccines; 2011 Aug; 10(8):1169-82. PubMed ID: 21854310
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of naked DNA uptake and expression.
Wolff JA; Budker V
Adv Genet; 2005; 54():3-20. PubMed ID: 16096005
[TBL] [Abstract][Full Text] [Related]
7. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
Wozniak TM; Ryan AA; Triccas JA; Britton WJ
Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
[TBL] [Abstract][Full Text] [Related]
8. Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine.
Herd KA; Wiethe C; Tindle RW
Vaccine; 2007 Jul; 25(28):5209-19. PubMed ID: 17544551
[TBL] [Abstract][Full Text] [Related]
9. Skin-specific promoters for genetic immunisation by DNA electroporation.
Vandermeulen G; Richiardi H; Escriou V; Ni J; Fournier P; Schirrmacher V; Scherman D; Préat V
Vaccine; 2009 Jul; 27(32):4272-7. PubMed ID: 19450641
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccines--challenges in delivery.
Pachuk CJ; McCallus DE; Weiner DB; Satishchandran C
Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.
Fredriksen AB; Sandlie I; Bogen B
Mol Ther; 2006 Apr; 13(4):776-85. PubMed ID: 16414309
[TBL] [Abstract][Full Text] [Related]
12. Current developments in viral DNA vaccines: shall they solve the unsolved?
Rajcáni J; Mosko T; Rezuchová I
Rev Med Virol; 2005; 15(5):303-25. PubMed ID: 15906276
[TBL] [Abstract][Full Text] [Related]
13. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle.
Taniyama Y; Tachibana K; Hiraoka K; Aoki M; Yamamoto S; Matsumoto K; Nakamura T; Ogihara T; Kaneda Y; Morishita R
Gene Ther; 2002 Mar; 9(6):372-80. PubMed ID: 11960313
[TBL] [Abstract][Full Text] [Related]
14. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
[TBL] [Abstract][Full Text] [Related]
15. [DNA vaccines].
Smahel M
Cas Lek Cesk; 2002 Sep; 141 Suppl():26-32. PubMed ID: 12428419
[TBL] [Abstract][Full Text] [Related]
16. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
Xu J; Xu W; Chen X; Zhao D; Wang Y
Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
[TBL] [Abstract][Full Text] [Related]
17. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
U'Ren L; Kedl R; Dow S
Cancer Gene Ther; 2006 Nov; 13(11):1033-44. PubMed ID: 16841080
[TBL] [Abstract][Full Text] [Related]
19. Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen.
Schirmbeck R; Reimann J
Biol Chem; 2001 Apr; 382(4):543-52. PubMed ID: 11405219
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant effects of plasmid-generated hairpin RNA molecules on DNA vaccination.
Li D; Liu Y; Zhang Y; Xu J; Hong K; Sun M; Shao Y
Vaccine; 2007 Sep; 25(39-40):6992-7000. PubMed ID: 17716788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
